Stocktoria
Alkermes plc. ALKS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1991-07-16
Alkermes plc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Wright Christopher I | director | 2026-06-12 | Sell | 2,000 | $45.10 |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 2026-06-04 | Sell | 2,034 | $43.05 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-06-01 | Option exercise | 5,000 | $19.34 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-06-01 | Sell | 9,000 | $41.67 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | 2026-05-29 | Option exercise | 12,825 | $19.34 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | 2026-05-29 | Sell | 16,217 | $42.36 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | 2026-05-29 | Option exercise | 3,392 | $20.03 |
| Wright Christopher I | director | 2026-05-21 | Option exercise | 6,142 | — |
Source: SEC EDGAR filings · CIK 0001520262 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.